pembrolizumab
merck
['pembro', 'key,note,789', 'sclc', 'nsclc']
 keynote-789 didnt ahow benifits in os or pfs for nsclc with mutant egfr post osimiritinib showed no benefit of adding pembro as consistent with previous trial for egfr resistance
new tki? adc? #asco23 
PharmD, BCPS, BCOP | Hematology/Medical Oncology Clinical Pharmacist | Deputy Program Director Hematology/Oncology Pharmacy Residency Program @KFMC_RIYADH